Commentary and Analysis

Following high profile pauses to the AstraZeneca and Johnson & Johnson vaccines, as well as surging cases in different parts of the world, it is clear that the gains in some countries do not signal an end to the pandemic.

Elizabeth Shackelford explains why it's time for Congress to reassert limitations on our use of war.

Although the Biden administration has taken steps to address climate change, US policymakers and elites are split on the issue's threat level.

Council surveys find an American public split on the threat of climate change but open to cooperative efforts to limit its effects.

With high-profile suspensions of the AstraZeneca and Johnson and Johnson vaccine, fear of potential side effects and uneven efficacy of vaccine rollouts are causing concern for some.

Matt Abbott discusses the Biden administration's approach to North Korea.

Craig Kafura examines Americans' views on boycotting the 2022 Olympics in Beijing.

Outbreaks continue to emerge even as vaccinations increase; some countries feel safe to engage in more normal activities while others introduce new restrictions.

The Midwest's colleges and universities are central to community economic renewal and COVID-19 recovery, a revival put at risk by recent fiscal, demographic and short-sighted public policy headwinds.

Elizabeth Shackelford recounts her experiences working for the State Department and emphasizes the advantages a more diplomatic foreign policy.